Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: Mist - You Need To See This

Milestone Pharmaceuticals Q1 Earnings Call Highlights

Milestone Pharmaceuticals (NASDAQ:MIST) said its first quarter of 2026 marked the beginning of commercial sales for CARDEMYST, its newly approved treatment for acute episodes of paroxysmal supraventricular tachycardia, or PSVT, while the company also moved ahead with a Phase 3 program in atrial fibr

MarketBeat

Wings’ Arike Ogunbowale Arrested, Charged With Battery at Miami Nightclub

Ogunbowale was arrested and charged with misdemeanor battery on Thursday, according to Miami-Dade County records.

Sports Illustrated

Watch Arike Ogunbowale’s Clutch Three-Pointer That Sent Mist to Unrivaled Finals

Ogunbowale helped lift her team to a spot in the Unrivaled championship game after Monday night’s win over the Breeze.

Sports Illustrated

From analysis to the latest developments in health,
read the most diverse news in one place.

Who Should Be Unrivaled’s MVP? The Case For and Against Every Contender

Chelsea Gray? Paige Bueckers? Someone else? With Unrivaled’s regular season coming to a close, let’s look at the top candidates for the award.

Sports Illustrated

New on HBO Max in February 2026: All the new shows and movies to watch

There's plenty to check out on HBO and Max this February, and we've rounded up our favorite picks.

Tom’s Guide

Ranking the Top Lineups in Unrivaled for the 2026 Season

Which team has the best trio in the league? It’s time to run the stats and find out.

Sports Illustrated

New on HBO Max in January 2026: All the new shows and movies to watch

There's plenty to check out on HBO and Max this January, and we've rounded up our favorite picks.

Tom’s Guide

Read news from The Economist, FT, and more,
with one subscription

Why Is Milestone Pharmaceuticals Stock Plunging On Friday?

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) moved closer to potential FDA approval for its Cardamyst (etripamil) nasal spray, an investigational therapy for paroxysmal supraventricular tachycardia (PSVT), as the U.S. Food and Drug Administration (FDA) accepted the company’s response to prior issues.

Benzinga

New on HBO and Max in February 2025 — all the new shows and movies to watch

There's plenty to check out on HBO and Max this February, and we've rounded up our favorite picks.

Tom’s Guide

Unrivaled Week 2 storylines to watch, including what’s next for Angel Reese

Here's what you need to know about Unrivaled Week 2.

USA Today Sports Media Group

"Barmy night in Bracknell" promised as Spriggan Mist joined by EBB, Haze and Kindred Spirit for Four Play Progfest III

Bracknell prog all dayer Four Play Progfest III returns for the frst time since 2017, taking place on November 9

Louder

Former Met officer ‘shocked’ to realise she was still Wayne Couzens’ case officer, hearing told

Former PC Samantha Lee was the officer investigating an allegation of indecent exposure by Wayne Couzens

Evening Standard

Ex-Met constable ‘shocked to realise she was still Wayne Couzens case officer’

Samantha Lee is said to have failed to make the correct inquiries over two incidents when Sarah Everard’s killer exposed himself at a McDonald’s.

The Independent UK

15 years ago, a Stephen King sci-fi classic became his most infamous movie

A single change to the story sparked controversy... and praise. Here's how 'The Mist' redefined one of Stephen King's best stories.

Inverse

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Milestone Pharmaceuticals: Q1 Earnings Insights

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Milestone Pharmaceuticals: Q4 Earnings Insights

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:20 AM. Here's what investors need to know about the announcement.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.